Moteur de recherche d’entreprises européennes
Financement de l’UE (2 398 219 €) : Un pipeline complet de recherche translationnelle et de formation exploitant le métabolisme des lipides pour améliorer la prise en charge du cancer de la prostate … Hor28/06/2023 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Un pipeline complet de recherche translationnelle et de formation exploitant le métabolisme des lipides pour améliorer la prise en charge du cancer de la prostate et former les jeunes chercheurs à la lutte contre les maladies complexes
PROSTAMET is an immersive Doctoral Network (DN), that aims to train the next generation of researchers tackling complex multifactorial diseases, including cancer, that are typically characterized by an outspoken inter- and intra-patient heterogeneity and that increasingly face our ageing society. Despite unprecedented technological advances to dissect disease into its smallest details, the translation into cost-effective and personalised treatment approaches is one of the timeliest challenges that face the scientific community and that require a specific transdisciplinary mindset and education. Focusing on prostate cancer as a key paradigm of such a complex disease and as one of European Health Union’s new focus areas for organised screening, PROSTAMET aims to bridge current gaps in translational research, capitalising on the underexplored clinical potential of altered lipid metabolism in cancer. Through a close collaboration among well-selected academic and non-academic partners with highly complementary expertise, PROSTAMET aims to set up a unique lipid-focused translational research pipeline from cutting-edge spatially-resolved molecular discovery, through validation in gold-standard models, all the way to innovative drug development. Through its modular and bidirectional nature with multiple entry points, this pipeline is expected to generate outputs at multiple levels of the drug development chain for sustainable downstream valorisation. Through a combination of high-level technological “hands-on” research, non-academic placements and courses/workshops on scientific and complementary “soft” skills facilitated by the academic/non-academic composition of the consortium, PROSTAMET’s ambition is to provide young researchers with a creative and holistic view on translational research along with strong transferable skills to prepare them to take up thriving careers in a transformative health care system focusing on personalised precision medicine.
| Aspect Analytics | ? |
| Centre National de la Recherche Scientifique CNRS | 282 694 € |
| Institut National de la Sante et de la Recherche Medicale | 282 694 € |
| Instituto Portugues de Oncologia do Porto Francisco Gentil ΕΠΕ | 243 403 € |
| Katholieke Universiteit Leuven | 525 240 € |
| Universita Degli Studi Del Piemonte Orientale Amedeo Avogadro | 259 438 € |
| Universita Degli Studi Di Perugia | 259 438 € |
| Universite Clermont Auvergne | 282 694 € |
| Universite de Namur | 262 620 € |
https://cordis.europa.eu/project/id/101120283
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Aspect Analytics SA, Genk, Belgique.
